January 2020 FDA Recall Clonidine Hydrochloride by Unichem Pharmaceuticals Usa Inc
D-0829-2020 - Failed Impurities/Degredation Specifications

This Class III drug recall was voluntarily initiated by Unichem Pharmaceuticals Usa Inc on January 29, 2020 for the product Clonidine Hydrochloride. The FDA reported the reason for recall as failed impurities/degredation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0829-2020

Reason for Recall
Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label.
Initiated
01-29-2020
Reported
02-12-2020
Quantity
19161600 units

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
UNICHEM PHARMACEUTICALS USA INC
Distributed Nationwide in the US
Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem Laboratories Ltd. Pilerne Ind. Estate, Pilerne Bardez, Goa 403 511 India. Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816. NDC 29300-135-01

Batch or Lot Expiration Information

Lot# Lot Numbers: GCLL18108, GCLL18109, GCLL18110 - EXP 10/31/2020; GCLL19003 EXP 12/31/2020